Table 5.

Association between any drug sensitivity patterns and TB type, major lineage, sub-lineage and dominant strains

Variable	Any drug resistance
	Sensitive (%)	Resistant (%)	Total (%)	χ2 (df)	P- value
TB type
Extra-pulmonary	10 (76.9%)	3 (23.1%)	13 (14%)	0.233 (1)	0.629
pulmonary	66 (82.5%)	14 (17.5%)	80 (86%)
Major lineage by CBN
EA	47 (79.7%)	12 (20.3%)	59 (63.4%)	0.757 (2)	0.757
IO	15 (83.3%)	3 (16.7%)	17 (19.4%)
EAI	14 (87.5%)	2 (12.5%)	16 (17.2%)
Sub-lineage/Clade
AFRI	4 (100%)	0	4 (4.3%)
CAS	3 (100%)	0	3 (3.4%)
CAS1-Delhi	12 (100%)	0	12 (12.8%)
CAS1-Kili	2 (40.0%)	3 (60.0%)	5 (5.3%)
EAI1-SOM	1 (100%)	0	1 (1.1%)
H	3 (100%)	0	3 (3.4%)
H1	0	2 (100%)	2 (2.1%)
H3	2 (66.7%)	1 (33.3%)	3 (3.4%)
H3-Ural-1	1 (100%)	0	1 (1.1%)
H37Rv	1 (100%)	0	1 (1.1%)
H4-Ural-2	3 (100%)	0	3 (3.4%)
Manu_ancestor	0	1 (100%)	1 (1.1%)	34.861(22)	0.040
Manu1	3 (75%)	1 (25%)	4 (4.3%)
Manu2	6 (75%)	2 (25%)	8 (8.5%)
Manu3	7 (70%)	3 (30%)	10 (10.6%)
PINI	1 (100%)	0	1 (1.1%)
T	17 (94.4%)	1 (5.6%)	18 (19.1%)
T-Tuscany	1 (100%)	0	1 (1.1%)
T1-RUS2	0	1 (100%)	1 (1.1%)
T3	1 (100%)	0	1 (1.1%)
T3-ETH	6 (85.7%)	1 (14.3%)	7 (7.4%)
T4	2 (66.7%)	1 (33.3%)	3 (3.4%)
Turkey	1 (100%)	0	1 (1.1%)
Dominant strains
Orphan	66 (86.8%)	13 (76.5%)	79 (84.9%)
SIT1166	1 (1.3%)	0 (0.0%)	1 (1.1%)
SIT1251	1 (1.3%)	0 (0.0%)	1 (1.1%)
SIT1378	1 (1.3%)	1 (5.9%)	2 (2.2%)
SIT1475	1 (1.3%)	0 (0.0%)	1 (1.1%)	16.948(10)	0.076
SIT149	3 (3.9%)	0 (0.0%)	3 (3.2%)
SIT1547	1 (1.3%)	0 (0.0%)	1 (1.1%)
SIT1802	0 (0.0%)	1 (5.9%)	1 (1.1%)
SIT47	0 (0.0%)	1 (5.9%)	1 (1.1%)
SIT53	2 (2.6%)	0 (0.0%)	2 (2.2%)
SIT612	0 (0.0%)	1 (5.9%)	1 (1.1%)
Clustering
Yes	10 (62.5%)	6 (37.5%)	16 (17.2)	4.779 (1)	0.029
No	66 (85.7%)	11 (14.3%)	77 (82.8)